Claritev Gross Margin 2019-2025 | CTEV
Current and historical gross margin for Claritev (CTEV) over the last 10 years. The current gross profit margin for Claritev as of March 31, 2025 is %.
| Claritev Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-03-31 | $0.93B | $0.69B | 74.30% |
| 2024-12-31 | $0.93B | $0.69B | 74.30% |
| 2024-09-30 | $0.94B | $0.70B | 74.20% |
| 2024-06-30 | $0.96B | $0.71B | 74.45% |
| 2024-03-31 | $0.96B | $0.72B | 74.79% |
| 2023-12-31 | $0.96B | $0.73B | 75.47% |
| 2023-09-30 | $0.96B | $0.73B | 76.12% |
| 2023-06-30 | $0.97B | $0.75B | 77.12% |
| 2023-03-31 | $1.02B | $0.81B | 79.17% |
| 2022-12-31 | $1.08B | $0.88B | 81.09% |
| 2022-09-30 | $1.14B | $0.94B | 82.75% |
| 2022-06-30 | $1.17B | $0.99B | 84.07% |
| 2022-03-31 | $1.16B | $0.98B | 84.40% |
| 2021-12-31 | $1.12B | $0.94B | 84.42% |
| 2021-09-30 | $1.07B | $0.87B | 81.19% |
| 2021-06-30 | $1.01B | $0.70B | 69.70% |
| 2021-03-31 | $0.94B | $0.63B | 66.63% |
| 2020-12-31 | $0.94B | $0.62B | 65.99% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.353B | $0.931B |
| Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $39.281B | 54.26 |
| Hims & Hers Health (HIMS) | United States | $12.358B | 128.40 |
| Tempus AI (TEM) | United States | $10.796B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.614B | 72.09 |
| IRhythm Technologies (IRTC) | United States | $4.399B | 0.00 |
| Privia Health (PRVA) | United States | $3.055B | 208.83 |
| Enovis (ENOV) | United States | $2.089B | 11.65 |
| Clover Health Investments (CLOV) | United States | $1.773B | 0.00 |
| Schrodinger (SDGR) | United States | $1.765B | 0.00 |
| Phreesia (PHR) | United States | $1.531B | 0.00 |
| Azenta (AZTA) | United States | $1.296B | 60.21 |
| Omnicell (OMCL) | United States | $1.286B | 22.69 |
| 10x Genomics (TXG) | United States | $1.161B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.613B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.581B | 0.00 |
| Talkspace (TALK) | United States | $0.515B | 154.00 |
| Veradigm (MDRX) | United States | $0.455B | 0.00 |
| Standard BioTools (LAB) | United States | $0.441B | 0.00 |
| TruBridge (TBRG) | United States | $0.395B | 875.67 |
| Health Catalyst (HCAT) | United States | $0.315B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.212B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.204B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.151B | 0.00 |
| Pulmonx (LUNG) | United States | $0.148B | 0.00 |
| American Well (AMWL) | United States | $0.113B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.087B | 0.00 |
| CareCloud (CCLD) | United States | $0.086B | 3.27 |
| Retrieve Medical Holdings (RMHI) | United States | $0.083B | 0.00 |
| 111 (YI) | China | $0.068B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.061B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| HeartBeam (BEAT) | United States | $0.058B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |